Multiple sclerosis is not a movement disorder. It is classified as an autoimmune demyelinating disease of the central nervous system, a fundamentally different category. However, MS frequently causes movement problems, which is why the question comes up so often. Nearly half of people with MS experience tremor, roughly half develop significant muscle stiffness, and many deal with balance and coordination difficulties. These symptoms overlap with what you’d see in classic movement disorders, but they arise through a completely different disease process.
How MS Differs From a Movement Disorder
Movement disorders are neurologic conditions defined by abnormal increases or decreases in voluntary and involuntary movement. The classic examples, like Parkinson’s disease and Huntington’s disease, typically involve damage to specific deep brain structures that control the initiation and coordination of movement. These conditions are fundamentally about the motor control circuitry itself breaking down.
MS works differently. In MS, the immune system attacks myelin, the insulating sheath that wraps around nerve fibers in the brain and spinal cord. This attack causes inflammation and scarring (the word “sclerosis” literally means scarring), which disrupts the electrical signals traveling along those nerves. Because these lesions can form almost anywhere in the central nervous system, MS produces a wide and unpredictable range of symptoms: vision problems, numbness, fatigue, cognitive changes, and yes, movement difficulties. The movement problems in MS are a consequence of widespread nerve damage, not a primary malfunction of the brain’s motor control centers.
Diagnosis reflects this distinction. MS is diagnosed using the McDonald criteria, which require evidence that lesions are spread across different areas of the central nervous system and have occurred at different points in time. Doctors look for this pattern on MRI scans and sometimes in spinal fluid. Movement disorders, by contrast, are typically diagnosed based on the specific type of abnormal movement and its clinical characteristics.
Why MS Causes So Many Movement Problems
Even though MS is not a movement disorder, movement symptoms are among the most common and disabling features of the disease. The reason is straightforward: the nerve pathways that control walking, coordination, and muscle tone run through the brain and spinal cord, exactly where MS causes damage. When myelin is stripped from these pathways, signals slow down, arrive garbled, or fail to reach their destination entirely.
Three major categories of movement problems affect people with MS: tremor, spasticity, and ataxia. They often coexist and can compound each other, making everyday tasks like walking, writing, or getting dressed significantly harder.
Tremor
Tremor affects an estimated 25 to 60 percent of people with MS, with large registry studies placing the figure around 45 to 47 percent. Severe tremor, the kind that seriously interferes with daily function, affects roughly 5 to 6 percent. The arms are the most commonly affected body part, and people are twice as likely to notice tremor in their dominant hand. MS tremor is thought to arise primarily from damage to the cerebellum or thalamus, brain regions involved in fine-tuning and coordinating movement. Unlike the resting tremor seen in Parkinson’s disease, MS tremor most often appears during intentional movement, like reaching for a cup.
Spasticity
Spasticity is a stiffness or tightness in the muscles caused by damaged nerve signals failing to properly regulate muscle tone. In one clinical study, 47 percent of MS patients had clinically significant spasticity. It can range from a mild feeling of tightness to painful, uncontrollable muscle spasms that limit mobility. Interestingly, some degree of spasticity can actually be helpful: when muscles are weakened by MS, the extra stiffness sometimes provides support that makes standing or walking easier. Treatment has to account for this balance.
Ataxia and Balance Problems
Coordination problems are common in MS and stem primarily from damage within the cerebellum or to the nerve connections running into and out of it. The cerebellum is particularly vulnerable in MS. One study of people with progressive forms of the disease found that nearly 39 percent of the cerebellar cortex was affected by demyelination. Damage to the front part of the cerebellum tends to cause gait ataxia, the unsteady, wide-based walk that many people with MS develop. Damage to the cerebellar peduncles, the major nerve highway connecting the cerebellum to the rest of the brain, is also frequently seen on MRI scans.
When MS Actually Mimics a Movement Disorder
In rare cases, MS lesions land in exactly the right spot to produce symptoms that look indistinguishable from a classic movement disorder. When demyelinating lesions form in the basal ganglia or upper midbrain, the deep brain structures typically involved in Parkinson’s disease, they can cause parkinsonism: slowness of movement, rigidity, and shuffling gait.
A prospective study following 336 MS patients over five years found that 3.6 percent had clinical parkinsonism. But the cause mattered: 75 percent of those cases turned out to be coincidental Parkinson’s disease (MS patients can develop other conditions too), 17 percent were caused by medications, and only one patient, about 8 percent of the parkinsonism cases, had symptoms directly caused by MS lesions in the basal ganglia. People with progressive forms of MS are more likely to develop these demyelination-related movement disorders, including those originating in the brainstem, cerebellum, and the structures deep in the brain.
Other movement disorder symptoms that MS can occasionally produce include dystonia (sustained abnormal postures), ballism (large flinging movements), and palatal myoclonus (rhythmic jerking of the roof of the mouth). These are considered to have a direct relationship with demyelinating lesions in critical locations, though they remain uncommon.
How Movement Symptoms Are Managed
Managing movement problems in MS takes a layered approach, starting with the least invasive options. Physical therapy is typically the foundation: stretching programs, gait assessment, and balance training can meaningfully improve function and reduce fall risk. For many people, consistent rehab work makes a bigger day-to-day difference than medication.
When spasticity is significant enough to limit function or cause pain, oral medications can help reduce muscle tone. Treatment is approached in steps, starting with oral options and escalating to targeted injections with botulinum toxin for specific muscle groups, or in severe cases, a surgically implanted pump that delivers medication directly to the spinal fluid.
For walking speed specifically, there is an FDA-approved medication (dalfampridine) designed to improve nerve signal conduction in demyelinated pathways. In clinical trials, people who responded to the drug showed an average 25 percent improvement in walking speed, measured on a timed 25-foot walk. It also improved walking endurance on a 6-minute walk test. Not everyone responds, and the medication carries a seizure risk, so it is not appropriate for people with a seizure history.
Tremor remains the most difficult movement symptom to treat in MS. It responds poorly to the medications used for other types of tremor, and physical therapy can help with compensatory strategies but rarely eliminates the tremor itself. In selected cases, deep brain stimulation or focused ultrasound targeting the thalamus has been explored, though outcomes vary.
The Practical Distinction
The classification of MS matters beyond semantics because it determines how the disease is treated at its root. Movement disorders like Parkinson’s are managed by replacing or mimicking lost brain chemicals or by modulating specific circuits. MS is treated by suppressing or modifying the immune system to prevent new attacks on myelin, combined with symptom-specific therapies for whatever problems the existing damage has caused. If MS were approached as a movement disorder, the underlying immune attack would go unchecked, and the disease would continue to progress.
So while MS is not a movement disorder, movement is one of the things it disrupts most. The overlap in symptoms explains why the question is common, and why neurologists who treat MS spend a significant portion of their time managing problems that look very much like what their colleagues in movement disorder clinics see every day.